News & Press Releases

The rapid expansion of GLP-1 receptor agonists into pediatric obesity care is fundamentally reshaping treatment frameworks, transitioning away from “watchful waiting” toward active, longitudinal management. Experts at the ASPEN 2026 Nutrition Science & Practice Conference highlighted that since the American Academy of Pediatrics released its 2023 guidelines, pharmacotherapy is now […]

For decades, patients with irritable bowel syndrome (IBS) have a identified food ingestion as a primary trigger of symptoms, yet this remained clinically underexplored. While classical food allergies play a minimal role, food intolerances particularly to fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) are now recognized as common contributors.

For decades, patients with irritable bowel syndrome (IBS) have a identified food ingestion as a primary trigger of symptoms, yet this remained clinically underexplored. While classical food allergies play a minimal role, food intolerances particularly to fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) are now recognized as common contributors.

Small intestinal microbial dysbiosis (SIMD) is characterized by an aberrant expansion of microbial populations in the small intestine, predominantly bacteria, with occasional involvement of archaea or fungi.